Immunity to Cancer

Content: 
CONFERENCE COMMITTEE, Page ii
Front Matter, Page iii
Copyright, Page iv
SENIOR AUTHORS, Pages xi-xiv
PREFACE, Pages xv-xvi, Arnold E. Reif, Malcolm S. Mitchell
ACKNOWLEDGMENTS, Page xvii
SOME KEY PROBLEMS FOR SUCCESS OF CLASSICAL IMMUNOTHERAPY, Pages 3-16, Arnold E. Reif
WHAT ARE TUMOR ANTIGENS?, Pages 17-27, E.S. Lennox
ANTIGENICITY OF SIMIAN VIRUS 40 TRANSFORMED CELLS, Pages 29-40, S.S. Tevethia, R.W. Anderson, H. Karjalainen, M.J. Tevethia, A.E. Campbell
CHARACTERISTICS OF TUMOR ANTIGENS ON TUMORS INDUCED BY CHEMICAL CARCINOGENS. SOME RECENT FINDINGS, Pages 41-53, Lloyd W. Law
IMMUNOBIOLOGY OF RAW117 LARGE CELL LYMPHOMA, Pages 55-68, Garth L. Nicolson, Christopher L. Reading, Jim Klostergaard
BIOCHEMICAL AND FUNCTIONAL PROFILES OF TWO UNIQUE MELANOMA ASSOCIATED ANTIGENS, Pages 69-84, Ralph A. Reisfeld, David A. Cheresh, Gregor Schulz, John R. Harper, Vito Quaranta
IDENTIFICATION AND CHARACTERIZATION OF HUMAN LEUKEMIA ASSOCIATED ANTIGENS, Pages 85-95, Jerome Ritz, Peter Hokland, Christine Murray, Lee M. Nadler
MONOCLONAL ANTIBODIES AGAINST GASTRO-INTESTINAL TUMOR ASSOCIATED ANTIGENS, Pages 97-107, Zenon Steplewski, Henry F. Sears, Hilary Koprowski
IMMUNODIAGNOSIS OF MALIGNANCY WITH MONOCLONAL ANTIBODIES TO CELL SURFACE ANTIGENS EXPRESSED BY NON-NEOPLASTIC CELLS, Pages 109-123, Noel L. Warner
HUMAN MONOCLONAL ANTIBODIES THAT DISTINGUISH CUTANEOUS MELANOMAS FROM BENIGN NEVI IN FIXED SECTIONS, Pages 125-130, Ashraf Imam, Malcolm S. Mitchell, Robert L. Modlin, Clive R. Taylor, Raymond A. Kempf, June Kan-Mitchell
HOST RESPONSE TO EPSTEIN-BARR VIRUS INFECTED B CELLS, Pages 133-148, Eva Klein
THE ROLE OF T LYMPHOCYTE SUBSETS IN THE REJECTION OF 3-METHYLCHOLANTHRENE INDUCED RAT SARCOMA Mc7, Pages 149-160, R.W. Baldwin, V. Britten, B. Ferry, S. Kay, R.A. Robins
THE HUMORAL IMMUNE RESPONSE TO HUMAN CANCER, Pages 161-172, Herbert F. Oettgen, Lloyd J. Old
RELEVANCE OF TUMOR MODEL ANTIGENICITIES TO HUMAN TUMOR IMMUNOLOGY, Pages 173-186, Arnold E. Reif
INTENSIFICATION OF TUMOR ANTIGENICITY, Pages 187-196, Morton D. Prager
EFFECTOR CELLS OF T CELL LINEAGE, Pages 197-204, Christopher S. Henney
MACROPHAGE EFFECTOR AND REGULATORY FUNCTIONS, Pages 205-216, Stephen W. Russell, Daniel R. Salomon
NATURAL KILLER (NK) CELLS: CHARACTERISTICS AND POSSIBLE ROLE IN RESISTANCE AGAINST TUMOR GROWTH, Pages 217-229, Ronald B. Herberman
UV LIGHT-INDUCED INCREASE IN IMMUNOGENICITY OF 3LL TUMOR CELLS, Pages 231-236, Samuele Peppoloni, Ronald B. Herberman, Eliezer Gorelik
SUPPRESSOR CELLS: T CELLS AND MACROPHAGES, Pages 239-251, Robert J. North
IDIOTYPES AND ANTI-IDIOTYPES, Pages 253-265, Neil Greenspan, Michael Seiden, Brian Clevinger, Moon Nahm, Charles Lutz, Timothy Bartholow, Robert Heuckeroth, Steven Fine, Joseph Davie
HUMAN T-T CELL INTERACTIONS, Pages 267-279, Robert R. Rich, Edward J. Fox, Jennifer M. Puck
LYMPHOKINES AS REGULATORS OF TUMOR CELL FUNCTION, Pages 281-293, Marion C. Cohen, Stanley Cohen
INTERFERONS: CYTOSTATIC AND IMMUNOMODULATORY EFFECTS, Pages 295-308, William E. Stewart II, D. Kay Blanchard
POSSIBLE ROLE OF IRON DEPLETION AS CAUSE OF TUMOR CELL CYTOTOXICITY INDUCED BY ACTIVATED MACROPHAGES, Pages 309-321, John B. Hibbs Jr., Read R. Taintor, Zdenek Vavrin
IMMUNOLOGICAL SURVEILLANCE REVISITED, Pages 323-345, Osias Stutman
AIDS and KAPOSI SARCOMA, Pages 347-361, John L. Fahey, Jeremy Taylor, Ramatollah Afrasiabi, Michael Weaver, Ronald Mitsuyasu
GENETICS AND IMMUNOLOGY OF THE P815-X2 MODEL, Pages 363-367, R. Michael Williams, Larry W. Kwak
SHED MEMBRANE VESICLES: A MECHANISM FOR TUMOR-INDUCED IMMUNOSUPPRESSION, Pages 369-373, Douglas D. Taylor, Elinor M. Levy, Paul H. Black
MODIFICATION OF THE INDUCTION OF BCGcw SUPPRESSOR CELLS BY MITOMYCIN C, Pages 375-380, Mark A. DeSilva, H. Terry Wepsic, Yutaka Mizushima, Gerta Janss, Daniel A. Nikcevich
IMMUNOMODULATION BY A LOW DOSE OF CYCLOPHOSPHAMIDE AS THE PRIMARY MECHANISM FOR THE CURE OF MICE BEARING A LARGE METASTATIC MOPC-315 TUMOR, Pages 381-385, Margalit B. Mokyr, Sheldon Dray, Michael Colvin
AN IMMUNOTHERAPEUTIC MODEL FOR MURINE TRANSITIONAL CELL CARCINOMAS, Pages 387-391, Victor K. Lee, William A. See, Ingegerd Hellström, Karl Erik Hellström
REGULATION OF HUMAN T CELL RESPONSES BY GAMMA INTERFERON (IFN-γ): STUDIES ON THE BINDING AND BIOLOGICAL EFFECTS OF IFN-γ ON DISTINCT T CELL SUBPOPULATIONS, Pages 393-397, Peter Scheurich, Ugur Ücer, Helge Bartsch, Klaus Pfizenmaier
BIOMODULATION: A CLASSIFICATION AND OVERVIEW, Pages 401-411, Malcolm S. Mitchell
ACTIVE SPECIFIC IMMUNOTHERAPY WITH EXTRACTED TUMOR-SPECIFIC TRANSPLANTATION ANTIGENS, Pages 413-427, B.D. Kahan, N.R. Pellis
ACTIVE SPECIFIC IMMUNOTHERAPY AS AN ADJUNCT TO THE TREATMENT OF METASTATIC SOLID TUMORS, Pages 429-442, Michael G. Hanna Jr., Herbert C. Hoover Jr.
CURRENT STATUS OF ACTIVE NON-SPECIFIC IMMUNOTHERAPY, Pages 443-452, Evan M. Hersh
ADOPTIVE CELLULAR IMMUNOTHERAPY, Pages 453-467, Martin A. Cheever, Philip D. Greenberg
THYMOSINS IN THE TREATMENT OF CANCER, Pages 469-483, Allan L. Goldstein, Richard S. Schulof
RESTORATIVE IMMUNOTHERAPY WITH INTERLEUKIN 2, Pages 485-498, Roland Mertelsmann, Karl Welte
STAPHYLOCOCCAL PROTEIN A COLUMN: ITS MECHANISM OF ACTION, Pages 499-511, Juergen H. Bertram
MATURATIONAL FACTORS IN MYELOID LEUKEMIA, Pages 513-529, Malcolm A.S. Moore, Janice L. Gabrilove, Karl Welte, Erich Platzer
In Vitro and In Vivo Stimulation of Murine Lymphocytes by Human Recombinant Interleukin 2, Pages 531-536, J.E. Talmadge, S. Dennis-Tait, M.E. Schneider, A.K. Meeker, J.S. Adams, J.R. Ortaldo, R.H. Wiltrout
CHEMO-ADOPTIVE IMMUNOTHERAPY OF MICE WITH ESTABLISHED CARCINOMAS USING INTERLEUKIN-2-PROPAGATED LYMPHOCYTES AND CRUDE LYMPHOKINE PREPARATIONS, Pages 537-542, Eli Kedar, Evelyne Chriqui-Zeira, Zulma Lebendiker
MODULATION OF IMMUNE FUNCTIONS BY INTERFERONS, Pages 545-559, Donna M. Paulnock, Ernest C. Borden
PASSIVE IMMUNOTHERAPY WITH MONOCLONAL ANTIBODIES TO DIFFERENTIATION ANTIGENS, Pages 561-574, Irwin D. Bernstein, Christopher C. Badger, Eric Denkers, Jeff Ledbetter
Antibody-Drug and Antibody-Toxin Conjugates, Pages 575-585, Robert K. Oldham
ANTIBODY-RADIOISOTOPE CONJUGATES FOR TUMOR LOCALIZATION AND TREATMENT, Pages 587-603, Steven M. Larson, Jorge A. Carrasquillo
VACCINATION AGAINST VIRALLY INDUCED ANIMAL TUMORS, Pages 605-617, Murray B. Gardner, Niels Pedersen, Preston Marx, Roy Henrickson, Paul Luciw, Raymond Gilden
THE BIOLOGY OF HEPATITIS B VIRUS AND HEPATOCELLULAR CARCINOMA, Pages 619-634, Arie J. Zuckerman
CHEMOIMMUNOTHERAPY – STRATEGY CONSIDERATIONS, Pages 635-641, Emil Frei III
CONFERENCE SUMMARY, Pages 643-645, Malcolm S. Mitchell
INDEX, Pages 647-659